BCFC/iStock Editorial through Getty Images
McKesson Corp. (NYSE:MCK) is in superior discussions to acquire a controlling stake in a privately held operator of oncology clinics.
Drug distributor McKesson (MCK) could supply about $3.5B for Florida Cancer Specialists & Research Institute, in accordance to a Bloomberg report on Friday, which cited individuals aware of the matter. A transaction may very well be introduced in the approaching weeks.
McKesson (MCK) was competing with different bidders for the oncology clinic enterprise, in accordance to the report.
McKesson (MCK) and Florida Cancer Specialists didn’t reply to Bloomberg requests for feedback.
Shares of McKesson (MCK) ticked decrease by 1.4% on Friday.
McKesson (MCK) is about to current on the 2024 Wells Fargo Healthcare convention on Sept. 5.
Source: Seekingalpha
